Video

Tim Turnham Discusses Melanoma Treatment Advances

Author(s):

Tim Turnham, PhD
Conference|ASCO Annual Meeting

Tim Turnham the Executive Director of the Melanoma Research Foundation Discusses Melanoma Treatment Advances

Tim Turnham, PhD, the Executive Director of the Melanoma Research Foundation (MRF) Discusses Melanoma Treatment Advances

Related Videos
Byoung Chol Cho, MD, PhD, professor, internal medicine, Division of Medical Oncology, Yonsei Cancer Center, Yonsei University College of Medicine
Stephen J. Freedland, MD
Ben Levy, MD, and Yan Leyfman, MD
Viktor Grünwald, MD, PhD
Aaron Gerds, MD
Sumanta Kumar Pal, MD, FASCO,
Stephen V. Liu, MD
S. Vincent Rajkumar, MD
Angela Jia, MD, PhD, of University Hospitals
Related Content
Ana C. Garrido-Castro, MD, a medical oncologist and codirector of the Triple-Negative Breast Cancer Working Group at Dana-Farber Cancer Institute and assistant professor of medicine at Harvard Medical School
June 2nd 2024

Pembrolizumab Plus Sacituzumab Govitecan Shows Nonsignificant Trend Toward Improved PFS in HR+ Breast Cancer

Jeffrey S. Weber, MD, PhD
November 6th 2023

FDA Approval Insights: Adjuvant Nivolumab in Completely Resected Stage IIB/C Melanoma

Jean-Marc Classe, MD, PhD
June 2nd 2024

Lymphadenectomy Fails to Boost Survival in Advanced Ovarian Cancer

Nikhil I. Khushalani, MD; Martin F. Dietrich, MD, PhD; Jason J. Luke, MD, FACP; Vishal A. Patel, MD, FAAD, FACMS
March 6th 2023

CSCC Experts Discuss Considerations for Determining Resectable Disease and Translating Data Into Practice

Suresh S. Ramalingam, MD, FACP, FASCO
June 2nd 2024

Osimertinib Could Alter SOC for Stage III EGFR+ NSCLC

Jens Hoeppner, FAChirg, FACS, MD
June 2nd 2024

Perioperative Chemotherapy Prolongs OS vs Neoadjuvant Chemoradiation in Esophageal Cancer